Tracy McCourt - 07 Dec 2020 Form 4 Insider Report for MedMen Enterprises, Inc.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
05 Oct 2021, 19:27:53 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tracy McCourt

Key filing fact

Tracy McCourt filed Form 4 for MedMen Enterprises, Inc. on 05 Oct 2021.

Key facts

  • This page summarizes Tracy McCourt's Form 4 filing for MedMen Enterprises, Inc..
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Oct 2021, 19:27.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMNFF transaction

Class B Subordinate Voting Shares

Award

Transaction value
$0
Shares
+477,417
Change %
Price
$0.000000
Shares after
477,417
Date
29 Aug 2021
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MMNFF transaction Derivative

Employee Stock Options (right to buy)

Award

Transaction value
$0
Shares
+307,180
Change %
Price
$0.000000
Shares after
307,180
Date
07 Dec 2020
Ownership
Direct
Underlying class
Class B Subordinate Voting Shares
Underlying amount
307,180
Exercise price
$0.1953
Footnotes
F1, F3
MMNFF transaction Derivative

Employee Stock Options (right to buy)

Award

Transaction value
$0
Shares
+120,209
Change %
Price
$0.000000
Shares after
120,209
Date
29 Aug 2021
Ownership
Direct
Underlying class
Class B Subordinate Voting Shares
Underlying amount
120,209
Exercise price
$0.2814
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Issued pursuant to Issuer's 2018 Stock Incentive Plan.

Footnote F2

Represents restricted stock units ("RSUs"), which vest annually over four years beginning 6/30/2022, with 37.5% of shares vesting on 6/30/2022 and 6/30/2024, and 12.5% of shares vesting on 6/30/2023 and 6/30/2025. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of such shares of Issuer.

Footnote F3

Such options have an exercise price of CAN$0.25, which is equivalent to US$0.1953 at an exchange rate of 1.2801.

Footnote F4

Such options have an exercise price of CAN$0.355, which is equivalent to US$0.2814 at an exchange rate of 1.2635.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .